Company news
Fresenius Se & Co. Kgaa (XETR:FRE) news
Every Fresenius Se & Co. Kgaa press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Fresenius SE & Co. KGaA: Sara Hennicken, buy
September 10, 2026
Fresenius : reorganizes its hospital services business
September 9, 2026
08.09.2026 - Fresenius SE & Co. KGaA: Michael Sen, buy (directors dealings?id=f4bde434 a9a0 477d be62 9746afea402b)
September 8, 2026
Fresenius Kabi Launches Generic Sugammadex in Simplist® Ready‑to‑Administer Prefilled Syringe in the U.S.
September 3, 2026
Fresenius Medical Care AG : Release of a capital market information
August 31, 2026
Fresenius raises approximately €300 million through sale of 7.8 million Fresenius Medical Care shares
August 20, 2026
Fitch Ratings upgrades outlook for Fresenius SE from stable to positive
August 10, 2026
Fresenius Kabi Issues Voluntary Nationwide Recall of One Lot of Morphine Sulfate Injection, USP in a Simplist® Prefilled Syringe Due to L...
August 4, 2026
Fresenius Announces FDA Approval of Rituximab Biosimilar for the U.S. Market
August 3, 2026
Fresenius : Announces FDA Approval of Rituximab Biosimilar for the U.S. Market
August 3, 2026
Fresenius Announces FDA and EMA Acceptance for Review of Vedolizumab Biosimilar Candidate
July 31, 2026
Fresenius establishes venture fund of more than €200 million to drive healthcare innovation
July 23, 2026
Fresenius Medical Care introduces TherapyWise™ analytics for kidney replacement therapy
July 20, 2026
Fresenius : Q2 2026 Aide Memoire available
July 15, 2026
Fresenius SE & Co. KGaA: Michael Sen, buy
June 1, 2026
Fresenius Medical Care highlights new renal research and innovation at ERA Congress 2026
May 27, 2026
2026 Annual General Meeting: Fresenius delivers strong performance in 2025 and proposes 5% increase in dividends
May 22, 2026
Fresenius Medical Care Reappoints Chief Financial Officer Martin Fischer
May 20, 2026
Fresenius invests in Avelios Medical and further expands its strategic partnership with SAP
May 6, 2026
CMS Grants Fresenius Kabi COVID-19 Indication-Specific HCPCS Codes for Tyenne® (tocilizumab-aazg)
April 9, 2026
AGM: Fresenius SE & Co. KGaA: Announcement of the Convening of the General Meeting in Frankfurt am Main on 22.05.2026 according to articl...
April 8, 2026
Dialysis Equipment Market Expands, Led by North America, Europe & Asia with Fresenius, Baxter Innovation
March 27, 2026
Fresenius : Supervisory Board extends ahead of schedule CEO Michael Sen’s contract by five years Christian Pawlu to join Management Board...
February 25, 2026
Fresenius Kabi, TQ Therapeutics Announce Cell Therapy Technology Agreement
January 14, 2026
Fresenius Kabi Introduces First-Ever Rocuronium Bromide Injection Stable at Room Temperature
December 18, 2025
mAbxience and HP drive the use of artificial intelligence in biomanufacturing and biosimilar development
December 4, 2025
Fresenius Kabi’s Adaptive Nomogram used on Aurora Xi Plasmapheresis System Now Operating Nationwide at BioLife Plasma Centers
November 12, 2025
FDA Grants Interchangeable Designation to Fresenius Kabi’s Biosimilars Conexxence® and Bomyntra® (denosumab-bnht)
October 29, 2025
Fresenius Kabi Receives Two Major Awards for Supply and Service Excellence from Vizient®
September 25, 2025
Fresenius Leads New EASYGEN Consortium Aimed at Decentralizing CAR-T Cell Therapy and Improving Hospital Workflows
August 26, 2025
Fresenius Kabi Receives 2025 Premier Supplier Legacy Award
July 17, 2025